Menu Back toSession 8 Track 1: Hot Topics

Medical Affairs and Scientific Communications Forum

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 8 Track 1: Hot Topics

Session Chair(s)

Amy  Van Sant, PharmD, MBA

Amy Van Sant, PharmD, MBA

  • President, Medical Affairs
  • Ashfield Engage, United States
Our environment is constantly changing, and companies face increasing challenges to deliver high-quality and impactful medical communications. This session will touch on three ‘hot topics’ trending in the industry that may shape how we work in the future. Guest speakers will review some of the cutting edge work they are doing around these hot topics. The format of this session will be informal and audience questions are encouraged.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss the complexities, challenges and successes in medical communications in light of FDA Guidance impacting medical communications
  • Examine on a global level the impact of health equity
  • Describe the impact of medical communications under an Emergency Use Authorizations (EUA)
  • Identify emerging trends and their impact on Medical Communications


Hira  Shah, PharmD

FDA Guidance

Hira Shah, PharmD

  • Director, Regulatory Affairs Advertising & Promotion
  • Regeneron, United States
Stephanie  Young Moss, PharmD, MS

Health Equity

Stephanie Young Moss, PharmD, MS

  • Pharmacist, Owner
  • Integrative Pharmacy Outcomes and Consulting, United States
Constance  Stangarone

Virtual Congresses

Constance Stangarone

  • Convention Services, Principal Manager
  • Genentech, United States